This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08195/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08195/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08195/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08195/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08195/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08195
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08195 n7:DB08195
dcterms:title
(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE
adms:identifier
n9:99444666 n10:MO9 n11:9547943 n12:7826878 n13:DB08195
n3:IUPAC-Name
n4:271B4082-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4088-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4087-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4084-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4085-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4086-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4080-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B407E-363D-11E5-9242-09173F13E4C5 n4:271B4081-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B407F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B408E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B408F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4089-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B408A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B408C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B408B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B408D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4094-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4096-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4097-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4093-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4092-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4095-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4083-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4090-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4091-363D-11E5-9242-09173F13E4C5